Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ExcelMab Logo
ExcelMab Growth Score
67
CB Rank
119725
Heat Score
61
ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients.
Founded
obfuscation
PrivateSeries A Guangzhou, Guangdong, China11-50 www.excelmab.com
Biotechnology
Health Care
Therapeutics
Overview

ExcelMab
Total Funding
obfuscation
Growth Score
67
Heat Score
61

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score67
-3 pts
in past quarter
Heat Score 61
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ExcelMab

CB Rank
119725
ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients.
Founded
obfuscation
PrivateSeries A Guangzhou, Guangdong, China11-50 www.excelmab.com
Biotechnology
Health Care
Therapeutics

Funding Rounds

Series A
OBF
in
obfuscation

Key People

Details

Legal Name Excelmab Inc.
Also Known As 瑞通生物
Operating Status Active
Company Type For Profit
Founders  Chunxu Yang, Wenjun Zhang
About the Company
ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients.
Phone Number 020-28211020
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ExMab® Platform
A technology platform for developing bispecific antibody molecules with improved stability and cost-effectiveness for tumor immunotherapy.
EX103 Injection
A CD20/CD3 bispecific antibody drug candidate for treating relapsed or refractory B-cell non-Hodgkin lymphoma.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - ExcelMab Logo
Series A - ExcelMab
7
obfuscation
— Series A
obfuscation
Series A - ExcelMab Logo
Series A - ExcelMab
7
obfuscation
— Series A
obfuscation
Series A - ExcelMab Logo
Series A - ExcelMab
7
obfuscation
— Series A
obfuscation
Series A - ExcelMab Logo
Series A - ExcelMab
7
obfuscation
— Series A
obfuscation
Series A - ExcelMab Logo
Series A - ExcelMab
7
obfuscation
— Series A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - ExcelMab Logo
Series A - ExcelMab
7
obfuscation
— Series A
obfuscation
Series A - ExcelMab Logo
Series A - ExcelMab
7
obfuscation
— Series A
obfuscation
Series A - ExcelMab Logo
Series A - ExcelMab
7
obfuscation
— Series A
obfuscation
Series A - ExcelMab Logo
Series A - ExcelMab
7
obfuscation
— Series A
obfuscation
Series A - ExcelMab Logo
Series A - ExcelMab
7
obfuscation
— Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Med-Fine Capital Logo
Med-Fine Capital
—
Series A - ExcelMab Logo
Series A - ExcelMab
—
Med-Fine Capital Logo
Med-Fine Capital
—
Series A - ExcelMab Logo
Series A - ExcelMab
—
Med-Fine Capital Logo
Med-Fine Capital
—
Series A - ExcelMab Logo
Series A - ExcelMab
—
Med-Fine Capital Logo
Med-Fine Capital
—
Series A - ExcelMab Logo
Series A - ExcelMab
—
Med-Fine Capital Logo
Med-Fine Capital
—
Series A - ExcelMab Logo
Series A - ExcelMab
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News
Technology
View Tech Report

Monthly Web Visits

155
3,000%
 in past month

Active Website Tech Count

6ExcelMab is actively using 6 technologies for its website, according to BuiltWith. These include SSL by Default, CommonCrawl Top 50m, and  SPF.

Total IP

9The intellectual property of ExcelMab includes 9 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is ExcelMab's headquarters? ExcelMab is located in Guangzhou, Guangdong, China.Who invested in ExcelMab? ExcelMab has 7 investors including Med-Fine Capital and  Talent Capital.When was the last funding round for ExcelMab? ExcelMab closed its last funding round on
obfuscation
from a Series A round.Who are ExcelMab's competitors? Alternatives and possible competitors to ExcelMab may include Pfizer, AbbVie, and  Roche.How much funding has ExcelMab raised to date? ExcelMab has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|